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Nasopharyngeal carcinoma in situ in
nasopharyngeal carcinoma
C W Chan, J M Nicholls, J S T Sham, P Dickens, D Choy
Abstract
Aims: To assess the presence ofcarcinoma
in situ (CIS) in patients with nasopharyn-
geal carcinoma (NPC) and to see if the
number of biopsy sites facilitates detec-
tion of CIS.
Methods: Formalin fixed, paraffin wax
embedded biopsy specimens (n = 285)
from 187 patients with NPC in 1987 were
studied for the presence of CIS as well as
for the histological assessment of the
subtype of CIS.
Results: Fifteen (8.0%) patients had CIS,
representing 8-3% of all new patients with
NPC and 11*6% ofpatients with persistent
disease or relapse. CIS was undifferen-
tiated or poorly differentiated, no cases of
well differentiated squamous celi CIS
were identified. There was no significant
difference in the incidence of CIS when
multiple endoscopic biopsy specimens
were taken rather than single forceps
biopsy specimens.
Conclusions: CIS can only be identified in
a few patients with NPC largely because of
late presentation with advanced disease at
the time of diagnosis and the focal nature
of the dysplastic process. The presence of
dysplasia in relapses ofNPC suggests that
these tumours may be second growths
rather than regrowths of a primary
tumour.
(7 Clin Pathol 1992;45:898-901)
yngeal carcinoma in situ using the two biopsy
techniques was also assessed.
Methods
The slides of all biopsy cases diagnosed in
1987 as undifferentiated carcinoma, anaplastic
carcinoma, and squamous cell carcinoma from
the nasopharynx were retrieved and examined.
If slides had faded they were restained and
extra sections were cut if necessary. The
specimens had all been fixed in 10% formalin,
embedded in paraffin wax, and the slides
stained with haematoxylin and eosin. The
presence or absence of tumour was confirmed.
Material from this period had been used in a
previous study.4 If more than one biopsy
specimen was taken from the nasopharynx
during an examination it was classified as a
multiple biopsy specimen. For the purpose of
this study the presence of carcinoma in situ
was characterised by the presence of cyto-
logical and architectural atypia affecting the
whole thickness of the epithelium. Also
assessed was whether such change was con-
tiguous with the invasive tumour. The assess-
ment was initially performed by one
pathologist (iN). To check for interobserver
error the cases diagnosed as CIS were ran-
domly distributed among those not showing
CIS and shown to two other pathologists
(CWC, PD). A Gomori reticulin stain was
performed to confirm the confinement of
atypia to the epithelium and to exclude inva-
sion whenever necessary.
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In 1837 Durand-Fardel reported a case of
nasopharyngeal carcinoma (NPC). One of the
first histological classifications was detailed in
1921 by Schmincke and by Cappell in 1934
and 1938. The high prevalence of NPC in
Hong Kong Chinese, was reported by Digby et
al in 1940-1941.lThe World Health Organisa-
tion classification introduced in 1978 has been
widely accepted and used,2 providing a useful
framework for classifying NPC and comparing
the results. However, precursor lesions for
NPC indicative of carcinoma in situ (CIS)
have not been studied in depth and there have
been only a few reports looking at the pathol-
ogy of these lesions. This study was therefore
undertaken to look at the prevalence of naso-
pharyngeal carcinoma in situ occurring in
cases of NPC seen within one year at our
hospital. As this was a period when both
multiple endoscopic and single forceps biopsy
specimens were used for the diagnosis of
NPC,' the efficacy of detecting nasophar-
Results
From January to December 1987 a total of 285
biopsy specimens from 187 patients were
positive for malignancy. Of these 187 patients,
144 (77%) had a total of 228 biopsy specimens
from primary growths for the initial assessment
and staging of the tumour; 43 (23%) patients
had a total of 57 specimens to assess tumour
relapse or residual disease, 12 weeks after the
completion of external radiation treatment. Of
the 228 specimens for initial tumour assess-
ment, 181 (79-3%) were multiple and 47
(20 6%) were single. For the 57 biopsy speci-
mens assessed for relapse or residual tumour,
38 (67%) were multiple and 19 (33%) were
single.
On initial examination a total of 21 speci-
mens from 18 patients had nasopharyngeal
carcinoma in situ of which 15 were taken from
primary growths and six were taken for the
evaluation of relapse or persistent tumour.
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Figure 1 Carcinoma in situ of a poorly differentiated type resembling transitional cel
carcinoma (haematoxylin and eosin).
Following a review by the two other patholo-
gists (PD, CWC) the distinction between in
situ change and tumour replacement of the
epithelium was considered too difficult to
make in two cases from primary growths and in
one from a recurrent tumour. These were
excluded so that in the final analysis there were
15 patients with CIS-1 1 with primary
growths and four with relapse. One patient had
nasopharyngeal carcinoma in situ in the pre-
Figure 2 Carcinoma in situ of an undifferentiated type (haematoxylin and eosin).
treatment biopsy specimens and in the recur-
rent tumour. CIS was therefore present in
8-0% of the patients with NPC. Eleven of 144
(7 6%) of all new patients with NPC had
nasopharyngeal carcinoma in situ and five of
43 (11 6%) with relapse or persistent tumour
showed the presence of nasopharyngeal carci-
noma in situ. Of all the 219 multiple biopsy
specimens, CIS was present in 14 (6 4%) and
in four (6-1%) of the 66 single biopsy speci-
mens. Two patients with both single and
multiple biopsy specimens taken had CIS.
There were no cases of well differentiated
squamous cell CIS. Seven of our cases were of
transitional or poorly differentiated type CIS
(fig 1) and eight were analogous with an
undifferentiated CIS using WHO criteria (fig
2), with an attenuated form of CIS identified
(fig 3). Continuity of the CIS with tumour
could only be confirmed in six cases.
Discussion
There are many types of neoplasm which may
arise in the nasopharynx and these reflect the
variety ofnormal tissue elements in this region.
The most common form of cancer in this area
is NPC.5 The epithelial nature of this tumour
has been well characterised by electron micros-
copy6 as well as by immunohistochemistry.'
There is little doubt that NPC originates in the
epithelium of the nasopharynx even though
continuity oftumour with the epithelium is not
always seen.8 Crypt epithelial cells may have a
role in NPC as they have similar histological
features to undifferentiated carcinoma.
Though we detected no single criterion to
differentiate dysplastic from normal epithe-
lium, we found that in the latter condition the
nuclear size and irregularity, prominence of
nucleoli, decrease of lymphocyte numbers and
absence of differentiation in the adjacent epi-
thelium allowed attenuated dysplasia to be
diagnosed in two cases.
There has been considerable disagreement
and discussion on the histopathology of NPC,
but the amount of information on precursor
lesions is, by comparison, minimal. One of the
first reports on nasopharyngeal carcinoma in
situ was byTeoh in 1957' in which he analysed
31 necropsies between 1949 and 1955, with
malignant growths in the nasopharynx. The
material is currently being reanalysed using
immunohistochemical techniques. In one of
his patients (case 6) he noted that as well as a
primary growth in the left tubal elevation
sections; ". . . other parts of the nasopharynx
reveal carcinoma in situ in the epithelium
lining a crypt in the posterior wall .. ." Unfor-
tunately there were no photographs to docu-
ment this lesion. In 1962 Liang et al looked at
500 fresh cases of NPC in the Chung Shan
Medical College (in the province of Guang-
dong in southern China). Of their 500 biopsy
cases 16 (3 2%) showed precancerous change,
17 (3-4%) showed CIS, and 34 (7 2%) showed
early invasive carcinoma. No mention was
made, however, of these changes in necropsy
material from cases without NPC.9
Wieland referred to nasopharyngeal carcin-
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Figure 3 Carcinoma in
situ of an undifferentiated
type occurring in
attenuated epithelium
(haematoxylin and eosin).
oma in situ in American referral cases ofNPC8
in which he stated that in keratinising squa-
mous cell carcinoma the tumour always occur-
red on the surface of the epithelium from
which it originated. An apparently in situ
component was frequently observed. By com-
parison, it was unusual to see an apparently in
situ component in non-keratinising tumours;
moreover, when this was seen it was difficult to
prove that it represented true in situ carcinoma
and not epithelial replacement from an under-
lying tumour.
For several years Chinese publications have
referred to the precursor lesions of NPC.' "
However, they use different terminologies
from those used in the West and their termin-
ologies have mainly been based on the mor-
phology seen in animal experiments. There are
three proposed gradings of abnormal findings
in the nasopharynx-namely, simple hyper-
plasia or metaplasia, atypical hyperplasia or
metaplasia, and carcinoma in situ. This classifi-
cation is therefore similar to the preneoplastic
lesions seen in the bladder. Most Western
researchers would consider carcinoma in situ
as atypia involving the whole thickness of the
epithelium when applied to squamous epith-
elium, but Li et al.'° state that CIS of the
nasopharynx does not always involve the whole
thickness of the epithelium and may be mani-
fest as a few atypical, morphologically abnor-
mal cancer cells among hyperplastic or
metaplastic tissue. The results of another
Chinese monograph" found 98 cases (8 6%)
of CIS/microinvasive carcinoma among 1136
cases of NPC biopsy specimens.
The first article devoted entirely to naso-
pharyngeal carcinoma in situ was only publi-
shed in 1986.12 The authors found an
incidence of 2-3% in 2742 biopsy specimens,
and of these, the abnormal cells occupied the
whole thickness of the epithelium in 85A4% of
cases while in 14-9% of cases the abnormal
cells occupied only part of it. Most of the
lesions were found in the surface epithelium
while only 1 8-4% were seen in the crypt
epithelium. In the cases of nasophryngeal
carcinoma in situ there was significantly more
nuclear DNA than in normal and metaplastic
squamous epithelium.
In an initial report'3 and later in a mono-
graph'4 Lee et al compared the nasopharyngeal
in situ and premalignant lesions to those in the
cervix and proposed the term nasopharyngeal
intraepithelial neoplasia (NPIN), with three
grades ranging from NPIN I to NPIN III.
Their data showed that 73-3% of cases ofNPC
were NPIN and 12-3% of surgical biopsy
specimens from the normal nasopharynx were
NPIN. They also found NPIN in 1-5% of a
series of necropsy cases.
Our results of 8-0% are closer to the findings
of Zong'2 and Liang9 than those of Lee.'4 The
discrepancy could be that we only looked at
CIS, which involves the whole thickness of the
epithelium, while Lee looked at all cases with
epithelial atypia. Clearly, pathologists have
been unable to agree on terminology, and what
is called dysplasia by some may be called atypia
by others." We therefore chose to concentrate
on looking at the high grade dysplastic lesions
and found that there was reliable interobserver
concordance for the diagnosis of such lesions.
The reason for looking at nasophyaryngeal
carcinoma in situ and classifying it is more
than an academic exercise: a recent study on
CIS in a selected population showed that the
categorisation of precursor lesions remains an
important aspect in the early detection of
NPC.16 Though Lee mentioned the presence
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of koilocytic changes in biopsy material,'4
other authors have not mentioned this, and we
found no convincing cases in which we could
identify this abnormality in our material where
NPC was present.
Our study is the first to use the multiple
biopsy technique to look at the presence or
absence of tumour and CIS. As Zong et al
mentioned in their earlier paper, by the nature
of its anatomical location the nasopharynx is
not easily accessible and the same degree of
accuracy cannot be applied to assessing naso-
pharyngeal carcinoma in situ as in the cervix.'2
Weiland also stated that the small size of biopsy
material did not facilitate an accurate, con-
sistent, and meaningful classification of NPC.
Though no mention was made of the site of the
biopsy in any of the preceding reports, we
assume that they were taken straight from the
tumour site and not adjacent to it. For the year
studied, about 80% of the biopsy specimens
for the initial assessment of NPC were multi-
ple; for relapses the single biopsy specimens
detected 33%. This is because the pretreat-
ment multiple biopsy technique was con-
sidered at that time to be important in the
staging of the tumour17 and the posttreatment
biopsy specimen was just to document the
presence or absence of tumour. We found CIS
in 6-8% of the multiple biopsy specimens and
in 6-1% of the single specimens; this difference
was not significant. The multiple biopsy tech-
nique may be advantageous for staging pur-
poses but it does not promise better detection
of CIS.
The prevalence of nasopharyngeal carci-
noma in situ associated with invasive NPC is
much less than CIN which has been used by
some as a model for the nasopharynx. We
attribute this to two reasons: first, we were
unable to visualise the nasopharynx in as great
a detail as the cervix. Secondly, and more
importantly, NPC tends to present at a later
stage than carcinoma of the cervix and most of
the biopsy specimens of tumour do not show
sufficient epithelium because this has been
replaced by tumour. It should also be appre-
ciated that CIS is an evolving lesion and the
biopsy specimen represents one stage in the
developing lesion. The tumour is also different
from the cervical lesion in that it does not
appear to go through all the stages of CIS
before frank invasion develops. In this respect
it is perhaps better to think of the nasophar-
yngeal mucosa as being more similar in beha-
viour to bladder rather than cervical mucosa.
One very interesting point of our study was
that five cases of nasopharyngeal carcinoma in
situ were found among the cases of relapse or
disease persisting 12 weeks after radiotherapy
had been completed. Four of these cases were
in relapse while one was persistent disease. If
the case of persistent disease is removed, there
were four cases occurring in 24 patients with
relapse (16-7%), a figure higher than that of
the primary cases. Traditionally, relapse has
been considered regrowth of tumour that has
not been eradicated, but our findings suggest
that it could represent a second growth.
Further study is being conducted in this area.
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